AWA
GILD icon

AGH Wealth Advisors’s Gilead Sciences GILD Stock Holding History

AGH Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Sell
2,038
-23
-1% -$3.03K 0.16% 110
2026
Q1 		$287K Buy
2,061
+50
+2% +$7K 0.21% 92
2025
Q4 		$247K Sell
2,011
-140
-7% -$17K 0.19% 99
2025
Q3 		$239K Sell
2,151
-78
-3% -$8.87K 0.18% 106
2025
Q2 		$247K Buy
2,229
+370
+20% +$39.4K 0.2% 100
2025
Q1 		$208K Buy
+1,859
New +$192K 0.2% 110

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AGH Wealth Advisors's GILD Position: Q2 2026 in Review

AGH Wealth Advisors reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $3.03K and leaving 2,038 shares worth $257K. The position accounts for 0.16% of the portfolio, ranked #110.

AGH Wealth Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $287K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AGH Wealth Advisors held 2,038 shares of Gilead Sciences worth $257K as of Q2 2026.
  • AGH Wealth Advisors sold 23 Gilead Sciences shares in Q2 2026, an estimated $3.03K.
  • Gilead Sciences made up 0.16% of AGH Wealth Advisors's portfolio in Q2 2026, its #110 holding.
  • AGH Wealth Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • AGH Wealth Advisors's Gilead Sciences position peaked at $287K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AGH Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.